By Scientia Professor Matthew Colm Kiernan

Books

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

Book Chapters

Park SB; Kiernan MC, 2023, 'Chemotherapy-Induced Cranial Nerve Damage', in Cranial Nerves in Neurology A Comprehensive and Systematic Evaluation of Cranial Nerves Pathology and Specific Conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23

Vucic S; Kiernan MC, 2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138

, 2023, 'Amyotrophic lateral sclerosis', in Advances in Magnetic Resonance Technology and Applications, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2

Vucic S; Kiernan MC, 2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1

Dharmadasa T; Huynh W; Kiernan MC, 2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia the Neuroscience of Dementia Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5

Huynh W; Lee M; Kiernan MC, 2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press, pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Routledge, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9

Hardiman O; Kiernan MC; Van den Berg LH, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders A Clinical Guide Second Edition, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8

huynh W; lee M; kiernan MC, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235

Kiernan MC, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9

Vucic S; Kiernan MC, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138

, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376

Farrar M; Kiernan MC, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2

Park SB; Kiernan MC, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b

Park SB; Kiernan MC, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3

Vucic O; Burke D; Kiernan MC, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104

Kiernan MC, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181

Lin CS; Kiernan MC; Burke D; Bostock H, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403

Burke D; Kiernan MC, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy 2 Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

KIERNAN MC; BURKE D; BOSTOCK H, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129

Kiernan MC; Burke D, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366

Kiernan MC, 2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences Volumes 1 4, pp. V2-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3

Kiernan MC, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642

Burke DJ; Mogyoros I; Kiernan MC; Bostock H, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154

Burke DJ; Kiernan MC; Mogyoros I; Bostock H, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53

Journal articles

Ribeiro FL; Zhu X; Ye X; Tu S; Ngo ST; Henderson RD; Steyn FJ; Kiernan MC; Barth M; Bollmann S; Shaw TB, 2025, 'An Annotated Multi-Site and Multi-Contrast Magnetic Resonance Imaging Dataset for the study of the Human Tongue Musculature', Scientific Data, 12, http://dx.doi.org/10.1038/s41597-025-05092-8

Krishnan D; Talbot DL; Ashhurst JF; Park SB; Vucic S; Timmins HC; Kiernan MC, 2025, 'Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-01570-6

Grima N; Smith AN; Shepherd CE; Henden L; Zaw T; Carroll L; Rowe DB; Kiernan MC; Blair IP; Williams KL, 2025, 'Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement', Molecular Neurodegeneration, 20, http://dx.doi.org/10.1186/s13024-025-00820-5

Graco M; Berlowitz DJ; Sawyer A; Holland AE; Carey KA; Ahamed Y; Ridgers A; Lannin NA; Wu P; Wheatley J; Vucic OS; Viera Souza T; Singh B; Thomas G; Talman P; Szollosi I; Sheean B; Rowe D; Rautela L; Piper A; Michael C; Menadue C; McLean A; Kosky C; Kiernan M; Howard ME; Hannan L; Dalziel K; Curtin D; Chao C; Braat S; Aiyappan V; Aickelin U, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): protocol for a process evaluation of a clinical trial', Trials, 26, http://dx.doi.org/10.1186/s13063-025-08784-z

Berlowitz DJ; Rowe D; Howard ME; Piper A; Graco M; Braat S; Singh B; Souza TV; Lannin N; McLean A; Sawyer A; Carey KA; Ahamed Y; Wu P; Wheatley J; Vucic OS; Thomas G; Talman P; Szollosi I; Sheean B; Rautela L; Michael C; Menadue C; Kosky C; Kiernan M; Holland A; Hannan L; Dalziel K; Curtin D; Chao C; Aiyappan V; Aickelin U, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial', Trials, 26, http://dx.doi.org/10.1186/s13063-024-08464-4

Douglas A; McPhee M; Fisher F; Cheng C; Henders A; Ziser L; Stout JC; Kiernan MC; Osborne R; Mathers S, 2025, 'Using cluster analysis to identify the health literacy strengths and challenges of people living with motor neurone disease in Australia', BMC Health Services Research, 25, http://dx.doi.org/10.1186/s12913-025-12998-x

Tse NY; Orlando IF; O'Callaghan C; Taylor NL; Shine JM; Zalesky A; Tu S; Ahmed RM; Halliday GM; Piguet O; Hodges JR; Kiernan MC; Lewis SJG; Devenney EM, 2025, 'Susceptibility to visual hallucinations in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: The role of dysfunctional attentional networks', Cortex, 192, pp. 213 - 226, http://dx.doi.org/10.1016/j.cortex.2025.08.014

Adler GL; Kiernan MC; Tan RH, 2025, 'The FindMNDBiomarker Program: Protein Changes in Motor Neuron Disease/Amyotrophic Lateral Sclerosis Postmortem Tissue and Biofluids', Annals of Neurology, 98, pp. 788 - 800, http://dx.doi.org/10.1002/ana.27300

Haidar M; Viden A; Daniel C; Cuic B; Wang T; Rosier M; Tomas D; Mills SA; Govier-Cole A; Djouma E; Perera ND; Luikinga S; Rytova V; Barton SK; Gonsalvez DG; Palmer LM; McLean C; Kiernan MC; Vucic S; Turner BJ, 2025, 'Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice', Progress in Neurobiology, 252, http://dx.doi.org/10.1016/j.pneurobio.2025.102809

Vucic S; Shahrizaila N; Kano O; Menon P; Agustini S; Kulkantrakorn K; Atchayaram N; Lee YC; Prado MB; Ng KWP; Chai J; Son B; Talman P; Nghia HTT; Tuan LTQ; Shibuya K; Izumi Y; Atsuta N; Henderson RD; Cui L; Liu M; Ohnmar O; Rabani R; Hong YH; Sung JJ; Fan D; Raykar V; Kuwabara S; Kim SH; Sobue G; Kiernan MC, 2025, 'Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis', Lancet Regional Health Western Pacific, 62, http://dx.doi.org/10.1016/j.lanwpc.2025.101684

Shaw TB; Ribeiro FL; Zhu X; Aiken P; Bollmann S; Bollmann S; Chang J; Chidley K; Dempsey-Jones H; Eftekhari Z; Gillespie J; Henderson RD; Kiernan MC; Ktena I; McCombe PA; Ngo ST; Taubert ST; Whelan BM; Ye X; Steyn FJ; Tu S; Barth M, 2025, 'Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease', Computers in Biology and Medicine, 196, http://dx.doi.org/10.1016/j.compbiomed.2025.110824

Calma AD; Pavey N; Silva CS; van den Bos MAJ; Yiannikas C; Farrar MA; Kiernan MC; Menon P; Vucic S, 2025, 'Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis', Clinical Neurophysiology, 174, pp. 105 - 113, http://dx.doi.org/10.1016/j.clinph.2025.03.044

Santos Silva C; Pavey N; Calma AD; Kiernan MC; Menon P; van den Bos M; Vucic S, 2025, 'Utility of Cortical Inhibitory and Facilitatory Neuronal Circuits in Amyotrophic Lateral Sclerosis Diagnosis', European Journal of Neurology, 32, http://dx.doi.org/10.1111/ene.70203

Swart G; Garg N; Skolka M; Yiannikas C; Vucic OS; Pollard J; Carroll A; Spies J; Kiernan M; Klein C; Park S, 2025, 'Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort (P10-11.033)', Neurology, 104, http://dx.doi.org/10.1212/wnl.0000000000212523

Eisen A; Vucic S; Kiernan MC, 2025, 'Amyotrophic lateral sclerosis represents corticomotoneuronal system failure', Muscle and Nerve, 71, pp. 499 - 511, http://dx.doi.org/10.1002/mus.28290

van den Bos MAJ; Menon P; Pavey N; Higashihara M; Kiernan MC; Vucic S, 2025, 'Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis', Brain, 148, pp. 1169 - 1179, http://dx.doi.org/10.1093/brain/awae317

Kiernan MC; Timmins HC, 2025, 'Utility of the Gold Coast criteria for amyotrophic lateral sclerosis: Experience with fast progressors', Journal of the Neurological Sciences, 470, http://dx.doi.org/10.1016/j.jns.2025.123417

Almgren H; Mahoney CJ; Huynh W; D’Souza A; Berte S; Lv J; Wang C; Kiernan MC; Calamante F; Tu S, 2025, 'Quantifying neurodegeneration within subdivisions of core motor pathways in amyotrophic lateral sclerosis using diffusion MRI', Journal of Neurology, 272, http://dx.doi.org/10.1007/s00415-025-12920-9

Kiernan MC, 2025, 'Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis', Eneurologicalsci, 38, http://dx.doi.org/10.1016/j.ensci.2025.100559

Hannaford A; Pavey N; Menon P; van den Bos MAJ; Kiernan MC; Simon N; Vucic S, 2025, 'Muscle ultrasound aids diagnosis in amyotrophic lateral sclerosis', Clinical Neurophysiology, 170, pp. 234 - 243, http://dx.doi.org/10.1016/j.clinph.2024.11.008

Back to profile page